Logotype for Paysafe Limited

Paysafe (PSFE) Q2 2026 earnings summary

Event summary combining transcript, slides, and related documents.

Logotype for Paysafe Limited

Q2 2026 earnings summary

13 Aug, 2026

Executive summary

  • Q2 2026 revenue grew 4% year-over-year to $447.4 million, with first half revenue up 7% and adjusted EBITDA down 2% to $102.8 million, reflecting increased marketing and IT investments.

  • Active consumers rose 8% year-over-year to 7.8 million, with double-digit growth in Latin America, iGaming, and PaysafeWallet in Europe.

  • Major legacy litigation (Farzad case) was resolved, removing a key overhang and contributing to higher restructuring and legal costs.

  • Completed significant debt refinancing, extending maturities and increasing revolver capacity, supporting deleveraging and liquidity.

  • Product vitality index improved to 20% for 2026, up from less than 2% three years ago, reflecting successful portfolio rationalization and product innovation.

Financial highlights

  • Q2 revenue: $447.4 million (+4% YoY); adjusted EBITDA: $102.8 million (-2% YoY); adjusted EPS: $0.43 (-7% YoY); adjusted net income: $23.1 million.

  • Gross profit (excl. D&A): $243.8 million, up from $238.0 million YoY; adjusted EBITDA margin: 23.0%, down from 24.5%.

  • Unlevered free cash flow: $44.8 million in Q2 (44% conversion); LTM unlevered free cash flow: $298 million, up 10% YoY.

  • Net leverage ratio: 5.3x at Q2 end, down from 5.5x at Q4; total debt reduced by $106 million since December 2025.

  • Net loss widened to $58.9 million, or $(1.13) per diluted share, due to higher restructuring and legal costs.

Outlook and guidance

  • Full-year 2026 guidance reaffirmed: revenue $1,790–$1,830 million, adjusted EBITDA $449–$464 million, adjusted EPS $1.90–$2.03, reflecting higher interest expense from refinancing.

  • Q4 expected to be the strongest quarter, driven by seasonality, sporting events, and marketing investments.

  • Anticipate $25–$30 million reduction in operating expenses in H2 versus H1, due to lower credit losses and front-loaded investments.

  • Vitality Index (revenue from new products) tracking to 19–20% for 2026.

  • Midterm net leverage target set at 3.5x, with year-end 2026 expected at 5.1–5.2x.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more